Status:
COMPLETED
Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank
Lead Sponsor:
Arab American University (Palestine)
Conditions:
Cancer and Chemotherapy Related Anemia
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The main purpose of this study is to examine the effect of using AVR on pain, stress, anxiety, and SE among adult cancer patients undergoing chemotherapy in the West Bank hospitals in Palestine. The m...
Detailed Description
This study was designed as a randomized control trial (RCT), including both pretest and posttest assessments. Participants were randomly assigned to either the intervention group, which received AR, ...
Eligibility Criteria
Inclusion
- Adult patients aged 18-60 years undergoing chemotherapy for breast or colon cancer.
- Stage I or II cancer, as defined by the study protocol.
- Manageable levels of pain, anxiety, and stress, appropriate for participation in the intervention.
- \-
Exclusion
- Age over 60 years.
- Cancer types other than breast or colon cancer.
- Severe pain, anxiety, or stress that could interfere with participation or require intensive care beyond the study scope.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07152938
Start Date
June 1 2023
End Date
October 30 2023
Last Update
September 15 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Jenin governmental hospital
Jenin, Palestinian Territories, 00970
2
AL-Watni governmental hospital
Nablus, Palestinian Territories, 00970
3
Thabet Thabet governmental hospital
Tulkarm, Palestinian Territories, 00970